Alshanafey Saud, Almanea Sarah Saud
From the Department of Surgery, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
From the Academic and Training Affairs, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Ann Saudi Med. 2025 May-Jun;45(3):165-168. doi: 10.5144/0256-4947.2025.165. Epub 2025 Jun 5.
Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is a rare disease but the most common cause of persistent neonatal hypoglycemia, often requiring early pancreatectomy. In cases of persistent/relapsed hypoglycemia, redo surgery may be necessary.
We report our experience with the redo of laparoscopic pancreatectomy at a tertiary healthcare center.
Single-center, retrospective study.
Tertiary health care center.
We conducted a retrospective review of the patients who underwent redo laparoscopic pancreatectomy between March 2004 and April 2021. Demographic, clinical, and follow-up data were collected and analyzed. Descriptive data were generated.
Feasibility and safety of the procedure. Success in controlling the PHHI.
82 patients.
We managed 82 patients with PHHI by pancreatectomy, 11 of whom (6 boys and 5 girls) required redo procedures to control hypoglycemia, with 2 needing 2 redo procedures. The mean age during the redo procedure was 21 months. The redo procedures were performed at a mean duration of 15.5 months after the primary pancreatectomy. All patients exhibited the histologically diffuse type. The mean follow-up was 7 years. All cases were managed successfully after the redo procedures. Six patients were on medical treatment, 4 developed diabetes mellitus, and 1 became euglycemic). Two patients developed severe pancreatitis postoperatively, 1 required drainage of the infected collection and 1 developed thrombosis of the inferior vena cava, which was managed with anticoagulation medication.
Redo laparoscopic pancreatectomy is feasible, safe, and effective option for managing persistent or recurrent hypoglycemia after primary pancreatectomy in diffuse PHHI. Sufficient experience with laparoscopic pancreatectomy is required for redo surgeries.
Retrospective design of the study may introduce bias.
婴儿持续性高胰岛素血症性低血糖症(PHHI)是一种罕见疾病,但却是持续性新生儿低血糖症最常见的病因,常需早期进行胰腺切除术。对于持续性/复发性低血糖症患者,可能需要再次手术。
我们报告在一家三级医疗中心进行再次腹腔镜胰腺切除术的经验。
单中心回顾性研究。
三级医疗中心。
我们对2004年3月至2021年4月期间接受再次腹腔镜胰腺切除术的患者进行了回顾性研究。收集并分析了人口统计学、临床和随访数据。生成了描述性数据。
手术的可行性和安全性。控制PHHI的成功率。
82例患者。
我们通过胰腺切除术治疗了82例PHHI患者,其中11例(6名男孩和5名女孩)需要再次手术以控制低血糖,2例需要进行2次再次手术。再次手术时的平均年龄为21个月。再次手术平均在初次胰腺切除术后15.5个月进行。所有患者组织学表现均为弥漫型。平均随访7年。再次手术后所有病例均成功治疗。6例患者接受药物治疗,4例患糖尿病,1例血糖恢复正常。2例患者术后发生严重胰腺炎,1例需要引流感染灶,1例发生下腔静脉血栓形成,通过抗凝药物治疗。
对于弥漫性PHHI患者,再次腹腔镜胰腺切除术是治疗初次胰腺切除术后持续性或复发性低血糖症的可行、安全且有效的选择。再次手术需要有足够的腹腔镜胰腺切除术经验。
本研究的回顾性设计可能会引入偏倚。